William Plovanic
Stock Analyst at Canaccord Genuity
(2.89)
# 1,292
Out of 5,182 analysts
181
Total ratings
35.58%
Success rate
0.01%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STIM Neuronetics | Maintains: Buy | $7 → $3 | $1.52 | +97.37% | 5 | Mar 19, 2026 | |
| HTFL HeartFlow | Maintains: Buy | $40 → $43 | $24.83 | +73.18% | 5 | Mar 19, 2026 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $7 | $4.24 | +65.09% | 7 | Mar 9, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $212 → $198 | $116.80 | +69.52% | 14 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $450 → $435 | $204.31 | +112.91% | 8 | Feb 19, 2026 | |
| ATRC AtriCure | Maintains: Buy | $64 → $53 | $29.07 | +82.32% | 13 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $112 → $109 | $62.82 | +73.51% | 15 | Feb 17, 2026 | |
| DXCM DexCom | Maintains: Buy | $99 → $95 | $62.22 | +52.68% | 10 | Feb 13, 2026 | |
| CVRX CVRx, Inc. | Maintains: Buy | $11 → $10 | $9.01 | +10.99% | 10 | Feb 13, 2026 | |
| AORT Artivion | Maintains: Buy | $51 → $48 | $34.17 | +40.47% | 5 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $35 | $18.61 | +88.07% | 7 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $147 → $148 | $100.70 | +46.98% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $89 → $87 | $81.05 | +7.34% | 30 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $18.55 | +61.73% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.31 | +74.59% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $87.92 | +2.37% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $90.89 | +11.12% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $8.97 | +67.22% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $330.36 | -14.03% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.83 | +130.84% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.33 | +802.26% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $67.70 | +3.40% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $20.21 | +137.51% | 5 | Aug 3, 2023 |
Neuronetics
Mar 19, 2026
Maintains: Buy
Price Target: $7 → $3
Current: $1.52
Upside: +97.37%
HeartFlow
Mar 19, 2026
Maintains: Buy
Price Target: $40 → $43
Current: $24.83
Upside: +73.18%
TriSalus Life Sciences
Mar 9, 2026
Maintains: Buy
Price Target: $7
Current: $4.24
Upside: +65.09%
iRhythm Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $212 → $198
Current: $116.80
Upside: +69.52%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $450 → $435
Current: $204.31
Upside: +112.91%
AtriCure
Feb 18, 2026
Maintains: Buy
Price Target: $64 → $53
Current: $29.07
Upside: +82.32%
Boston Scientific
Feb 17, 2026
Maintains: Buy
Price Target: $112 → $109
Current: $62.82
Upside: +73.51%
DexCom
Feb 13, 2026
Maintains: Buy
Price Target: $99 → $95
Current: $62.22
Upside: +52.68%
CVRx, Inc.
Feb 13, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $9.01
Upside: +10.99%
Artivion
Feb 13, 2026
Maintains: Buy
Price Target: $51 → $48
Current: $34.17
Upside: +40.47%
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $18.61
Upside: +88.07%
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $100.70
Upside: +46.98%
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $81.05
Upside: +7.34%
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $18.55
Upside: +61.73%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.31
Upside: +74.59%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $87.92
Upside: +2.37%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $90.89
Upside: +11.12%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $8.97
Upside: +67.22%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $330.36
Upside: -14.03%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.83
Upside: +130.84%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.33
Upside: +802.26%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $67.70
Upside: +3.40%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $20.21
Upside: +137.51%